Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Quick Stats
Jan 30, 202652.5
AI Score
HOLD0.38
Volume Ratio
Jan 30, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
RGC Stock Summary
Last updated Jan 30, 2026
RGC is currently trading at $24.99, positioned below its 200-day moving average of $63.41, suggesting bearish momentum. The stock has a 52-week range of $0.0928 to $950.
Technical Analysis: The 50-day moving average stands at $22.91, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 46.485, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.018, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RGC at 52.5/100 with a HOLD recommendation.
RGC (Regencell Bioscience Holdings Limited Ordinary Shares) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 46.485 |
| CMF (20) | 0.018 |
| ROC (10) | -16.866 |
| ADX (14) | 38.493 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.077 |
| AROONOSC (14) | -57.143 |
| WILLAMS %R (14) | -85.787 |
| MFI (14) | 54.146 |
RGC Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RGC Price vs Max Options Open Interest
RGC Max Change In Options Open Interest
RGC Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RGC Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RGC Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RGC Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Regencell Bioscience Holdings Limited Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RGC Moving Averages Analysis
Regencell Bioscience Holdings Limited Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
RGC (Regencell Bioscience Holdings Limited Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 28.18 |
| 20 | 32.22 |
| 30 | 28.71 |
| 50 | 22.91 |
| 100 | 19.24 |
| 200 | 63.41 |
RGC Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 16.0 billion |
| Earnings/Share ($) | -0.01 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | -- |
| Most Recent Quarter |
News: $RGC and $RILY stocks are showing potential for significant runs, with $RGC already up 3000% on calls. $RILY is expected to break $7 and potentially reach $10+, leading to a squeeze similar to $RGC due to low float and high short interest. Additionally, $CPHI and $SXTC are gaining momentum in the China pharma and AI sectors, respectively. Investors are advised to keep an eye on these stocks for potential opportunities.
Updated 2026-01-08 15:00:02